Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)
Clinical trial NCT03437278 · COMPLETED
Trial details
- NCT number
- NCT03437278
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-10-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.